Dutch venture builder NLC has announced a €20m first close for its new Health Impact Fund, from which it will invest in 40 startups, both new investments and follow-on. It’s targeting a final close of €100m later this year.
https://european-biotechnology.com/wp-content/uploads/2024/04/money-bag-1189868_1280.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-07-05 10:52:552024-07-09 16:38:49Dutch NLC has €20m in first close of new Health Impact Fund